Summary
Charles River Laboratories International Inc (Charles River) is a contract research organization (CRO) that provides a wide range of essential products and services to accelerate the research, drug discovery and development. It offers various basic research, drug discovery and safety assessment services. The organization also offers clinical support, manufacturing support and operations and staffing support. It focuses on providing solutions targeted against therapeutic areas of cardiovascular, central nervous system, endocrine/metabolic inflammation, oncology, ophthalmology, respiratory disease and musculoskeletal disease. Charles River caters its products and services to global pharmaceutical companies, biotechnology companies, government agencies, as well as leading hospitals and academic institutions around the world. It operates through a wide network facilities located worldwide. Charles River is headquartered in Wilmington, Massachusetts, the US.
Charles River Laboratories International Inc (CRL) - Medical Equipment - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.
Scope
- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
'
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Charles River Laboratories International Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Charles River Laboratories International Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Charles River Laboratories International Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Charles River Laboratories International Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
Charles River Laboratories International Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Charles River Laboratories International Inc, Medical Equipment, Deal Details 10
Partnerships 10
Molecular Imaging Enters into Co-Promotion Agreement with Oncotest 10
BioFocus Extends Agreement With Michael J. Fox Foundation For Parkinson's Disease 10
Charles River Labs Enters Into Agreement With Bruker For Axcess System 11
Reinnervate Enters Into Co-Marketing Agreement With Oncotest For Alvetex Scaffold Technology 12
BioFocus Enters Into Agreement With Michael J. Fox Foundation For Parkinson's Disease 13
BioFocus Enters Into An Agreement With Almac Group 14
ChanTest Corporation Enters Into Co-Marketing Agreement With Molecular Devices 14
Asset Transactions 15
AAIPharma Services Acquires Celsis Analytical Services From Celsis International 15
Acquisition 16
Charles River Labs Acquires Celsis International for USD212 Million 16
Charles River Labs Acquires Accugenix, Provider Of Microbe Identification Services, For US$17 Million 17
Charles River Laboratories International Inc - Key Competitors 19
Key Employees 20
Locations And Subsidiaries 22
Head Office 22
Other Locations & Subsidiaries 22
Recent Developments 25
Financial Announcements 25
Feb 14, 2017: Charles River Laboratories Announces Fourth-Quarter and Full-Year 2016 Results from Continuing Operations and Provides 2017 Guidance 25
Nov 02, 2016: Charles River Laboratories Announces Third-Quarter 2016 Results from Continuing Operations 28
Aug 03, 2016: Charles River Laboratories Announces Second-Quarter 2016 Results from Continuing Operations 30
May 04, 2016: Charles River Laboratories Announces First-Quarter 2016 Results from Continuing Operations 32
Feb 10, 2016: Charles River Laboratories Announces Fourth-Quarter and Full-Year 2015 Results from Continuing Operations and Provides 2016 Guidance 34
Other Significant Developments 37
Sep 29, 2016: PathoQuest Announces Partnership with Charles River Laboratories 37
Appendix 38
Methodology 38
About GlobalData 38
Contact Us 38
Disclaimer 38
List of Tables
Charles River Laboratories International Inc, Medical Equipment, Key Facts, 2016 1
Charles River Laboratories International Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 1
Charles River Laboratories International Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Charles River Laboratories International Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Charles River Laboratories International Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Charles River Laboratories International Inc, Deals By Market, 2011 to YTD 2017 8
Charles River Laboratories International Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Molecular Imaging Enters into Co-Promotion Agreement with Oncotest 10
BioFocus Extends Agreement With Michael J. Fox Foundation For Parkinson's Disease 10
Charles River Labs Enters Into Agreement With Bruker For Axcess System 11
Reinnervate Enters Into Co-Marketing Agreement With Oncotest For Alvetex Scaffold Technology 12
BioFocus Enters Into Agreement With Michael J. Fox Foundation For Parkinson's Disease 13
BioFocus Enters Into An Agreement With Almac Group 14
ChanTest Corporation Enters Into Co-Marketing Agreement With Molecular Devices 14
AAIPharma Services Acquires Celsis Analytical Services From Celsis International 15
Charles River Labs Acquires Celsis International for USD212 Million 16
Charles River Labs Acquires Accugenix, Provider Of Microbe Identification Services, For US$17 Million 17
Charles River Laboratories International Inc, Key Competitors 19
Charles River Laboratories International Inc, Key Employees 20
Charles River Laboratories International Inc, Subsidiaries 22
List of Figures
Charles River Laboratories International Inc, Medical Equipment, Deals by Type, 2011 to YTD 2017 1
Charles River Laboratories International Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 1
Charles River Laboratories International Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 1
Charles River Laboratories International Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 1
Charles River Laboratories International Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Charles River Laboratories International Inc, Medical Equipment, Deals by Type, 2011 to YTD 2017 6
Charles River Laboratories International Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Charles River Laboratories International Inc, Medical Equipment, Deals by Market, 2011 to YTD 2017 8
